Cargando…

Editorial: Recent 3D Tumor Models for Testing Immune-Mediated Therapies

Detalles Bibliográficos
Autores principales:	Zimmer, Jacques, Castriconi, Roberta, Scaglione, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637122/ https://www.ncbi.nlm.nih.gov/pubmed/34868086 http://dx.doi.org/10.3389/fimmu.2021.798493

Ejemplares similares

Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies
por: Vitale, Chiara, et al.
Publicado: (2022)

Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies
por: Marrella, Alessandra, et al.
Publicado: (2019)

Editorial: TGF-β as a Key Regulator of NK and ILCs Development and Functions
por: Bottino, Cristina, et al.
Publicado: (2021)

Editorial: Innovative 3D technologies in cancer immunity research and therapy
por: Gupta, Deepak, et al.
Publicado: (2023)

Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy
por: Zappasodi, Roberta, et al.
Publicado: (2022)

Editorial: Exploring oncolytic virus-mediated changes in immune microenvironment and immune cells in solid tumors
por: Zhang, Hongwei
Publicado: (2023)

Editorial: HLA-G-Mediated Immune Tolerance: Past and New Outlooks
por: Gregori, Silvia
Publicado: (2016)

Editorial: Recent Advances in Drosophila Cellular and Humoral Innate Immunity
por: Vesala, Laura, et al.
Publicado: (2020)

A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model
por: Marzagalli, Monica, et al.
Publicado: (2022)

Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors
por: Pesce, Silvia, et al.
Publicado: (2023)

Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy
por: Andersson, Patrik, et al.
Publicado: (2019)

Editorial: HSPs—Ambiguous Mediators of Immunity
por: Calderwood, Stuart K., et al.
Publicado: (2016)

Editorial: The Role of Optineurin in Immunity and Immune-Mediated Diseases
por: Smith, Andrew M., et al.
Publicado: (2019)

Editorial: Lysosomal peptidases in tumor immunity
por: Perišić Nanut, Milica, et al.
Publicado: (2023)

Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches
por: Bottino, Cristina, et al.
Publicado: (2014)

Editorial: Is the Recent Burst of Therapeutic Anti-tumor Antibodies the Tip of an Iceberg?
por: Kremer, Leonor, et al.
Publicado: (2018)

Editorial: Modulation of human immune parameters by anticancer therapies, volume II
por: Na, Il-Kang, et al.
Publicado: (2023)

Editorial: Odyssey of Surfactant Proteins SP-A and SP-D: Innate Immune Surveillance Molecules
por: Kishore, Uday, et al.
Publicado: (2020)

Editorial: Immune-Modulatory Effects of Vitamin D
por: Zughaier, Susu M., et al.
Publicado: (2020)

Editorial: Immune dysfunction in nephrotic syndrome - recent advances and new roads ahead
por: Seitz-Polski, Barbara, et al.
Publicado: (2022)

Editorial: Recent Developments in Haploidentical Hematopoietic Cell Transplantation: Therapy and Complications
por: Chang, Ying-Jun, et al.
Publicado: (2021)

NK Cell Function Regulation by TGF-β-Induced Epigenetic Mechanisms
por: Regis, Stefano, et al.
Publicado: (2020)

Editorial: Innate immune cell therapy of cancer
por: Khatwani, Natasha, et al.
Publicado: (2022)

3D Tumor Models and Their Use for the Testing of Immunotherapies
por: Boucherit, Nicolas, et al.
Publicado: (2020)

Editorial: Ankylosing Spondylitis and Related Immune-Mediated Disorders
por: Fiorillo, Maria Teresa, et al.
Publicado: (2019)

Editorial: Early Life Origins of Immune-Mediated Disease
por: Skevaki, Chrysanthi, et al.
Publicado: (2020)

Editorial: Insights in cytokines and soluble mediators in immunity: 2022
por: Melgrati, Serena, et al.
Publicado: (2023)

Editorial: Tumor-promoting immune cells: Cancer immune escape and beyond
por: Domblides, Charlotte, et al.
Publicado: (2023)

Impairment of NKG2D-Mediated Tumor Immunity by TGF-β
por: Lazarova, Mariya, et al.
Publicado: (2019)

Editorial: The role of angiogenesis and immune response in tumor microenvironment of solid tumor
por: Guo, Zichao, et al.
Publicado: (2023)

Recent Advances in Immune Cell Therapy for Glioblastoma
por: Kang, Xianhui, et al.
Publicado: (2020)

Editorial: Versatile Roles for B Cells in Tumor Immunity
por: Brossart, Peter
Publicado: (2022)

Editorial: Manipulation of immune-vascular crosstalk in solid tumors
por: Kumar, Vijay
Publicado: (2023)

Editorial: Ying and Yang Members of the Tumor Necrosis Factor Superfamily: Friends or Foes in Immune-Mediated Diseases and Cancer
por: Giwa, Adebola, et al.
Publicado: (2017)

Editorial: Modulation of Human Immune Parameters by Anticancer Therapies
por: Sack, Ulrich, et al.
Publicado: (2020)

Editorial: Regulation of Soluble Immune Mediators by Non-Coding RNAs
por: Bosisio, Daniela, et al.
Publicado: (2020)

Editorial: Innate Immune Cells and Inflammatory Mediators in Mucosal Pathologies
por: Maria, Leite-de-Moraes, et al.
Publicado: (2020)

Editorial: Nanoparticle-Mediated Signaling Rewiring and Reprogramming of Immune Responses
por: Quintana, Francisco J., et al.
Publicado: (2022)

Editorial: Kidney transplantation and immune-mediated nephropathies, Volume II
por: Grinyó, Josep M., et al.
Publicado: (2022)

Editorial: The Skin Immune Response to Infectious Agents
por: Conceição-Silva, Fatima, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_auf1gljsrpao461n2hgfvk4e5p